These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37566081)

  • 1. Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients.
    Butler AE; Moin ASM; Sathyapalan T; Atkin SL
    Cells; 2023 Aug; 12(15):. PubMed ID: 37566081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Components of the Complement Cascade Differ in Polycystic Ovary Syndrome.
    Butler AE; Moin ASM; Sathyapalan T; Atkin SL
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D.
    Moin ASM; Sathyapalan T; Butler AE; Atkin SL
    Front Endocrinol (Lausanne); 2022; 13():935750. PubMed ID: 36619572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity.
    Lewis RD; Narayanaswamy AK; Farewell D; Rees DA
    Clin Endocrinol (Oxf); 2021 Jan; 94(1):74-84. PubMed ID: 32865246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Adipsin and Reduced C5a Levels in the Maternal Serum and Follicular Fluid During Implantation Are Associated With Successful Pregnancy in Obese Women.
    Ramanjaneya M; Diboun I; Rizwana N; Dajani Y; Ahmed L; Butler AE; Almarzooqi TA; Shahata M; Al Bader MK; Elgassim E; Burjaq H; Atkin SL; Abou-Samra AB; Elrayess MA
    Front Endocrinol (Lausanne); 2022; 13():918320. PubMed ID: 35909516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women.
    Ramanjaneya M; Abdalhakam I; Bettahi I; Bensila M; Jerobin J; Aye MM; Alkasem M; Sathyapalan T; Atkin SL; Abou-Samra AB
    Front Endocrinol (Lausanne); 2021; 12():740703. PubMed ID: 35250845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity.
    Moin ASM; Sathyapalan T; Butler AE; Atkin SL
    Clin Endocrinol (Oxf); 2023 Jun; 98(6):796-802. PubMed ID: 36859809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome.
    Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
    Front Endocrinol (Lausanne); 2023; 14():1117761. PubMed ID: 37181037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging.
    Lynch AM; Palestine AG; Wagner BD; Patnaik JL; Frazier-Abel AA; Mathias MT; Siringo FS; Holers VM; Mandava N
    BMJ Open Ophthalmol; 2020; 5(1):e000361. PubMed ID: 32509962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    Satyaraddi A; Cherian KE; Kapoor N; Kunjummen AT; Kamath MS; Thomas N; Paul TV
    J Hum Reprod Sci; 2019; 12(2):78-84. PubMed ID: 31293320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy.
    Iacomino N; Vanoli F; Frangiamore R; Ballardini M; Scandiffio L; Bortone F; Andreetta F; Baggi F; Bernasconi P; Antozzi C; Cavalcante P; Mantegazza R
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-Sectional Study of Glomerular Hyperfiltration in Polycystic Ovary Syndrome.
    Butler AE; Lubbad W; Akbar S; Kilpatrick ES; Sathyapalan T; Atkin SL
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study.
    Fukui S; Ichinose K; Sada KE; Miyamoto J; Harigai M; Amano K; Atsumi T; Takasaki Y; Dobashi H; Arimura Y; Hasegawa H; Yuzawa Y; Yamagata K; Tsuboi N; Maruyama S; Matsuo S; Makino H; Maeda T; Kawakami A
    Scand J Rheumatol; 2020 Jul; 49(4):301-311. PubMed ID: 32286129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    Pokorska-Niewiada K; Brodowska A; Brodowski J; Szczuko M
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.